HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Presbycusis

Gradual bilateral hearing loss associated with aging that is due to progressive degeneration of cochlear structures and central auditory pathways. Hearing loss usually begins with the high frequencies then progresses to sounds of middle and low frequencies.
Also Known As:
Presbycuses
Networked: 230 relevant articles (13 outcomes, 56 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Hearing Loss (Hearing Impairment)
2. Sensorineural Hearing Loss
3. Tinnitus
4. Ototoxicity
5. Seizures (Absence Seizure)

Experts

1. Sun, Yu: 9 articles (12/2021 - 07/2010)
2. Kong, Wei-Jia: 6 articles (12/2021 - 07/2010)
3. Frisina, Robert D: 6 articles (06/2021 - 11/2005)
4. Zhu, Xiaoxia: 5 articles (06/2021 - 01/2007)
5. Yuan, Jie: 5 articles (03/2020 - 07/2015)
6. Zhao, Xue-Yan: 4 articles (12/2021 - 02/2013)
7. Kong, Wen: 4 articles (03/2020 - 07/2015)
8. Zhong, Yi: 4 articles (07/2015 - 07/2010)
9. Syka, Josef: 4 articles (08/2013 - 01/2007)
10. Iwai, Hiroshi: 4 articles (09/2012 - 03/2003)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Presbycusis:
1. gamma-Aminobutyric Acid (GABA)IBA
2. MineralocorticoidsIBA
3. 3' Untranslated Regions (3' UTR)IBA
4. 5' Untranslated Regions (5' UTR)IBA
5. SolutionsIBA
6. Dexamethasone (Maxidex)FDA LinkGeneric
7. Cisplatin (Platino)FDA LinkGeneric
8. Mitochondrial DNA (mtDNA)IBA
9. Galactose (Galactopyranose)FDA LinkGeneric
10. Biomarkers (Surrogate Marker)IBA

Therapies and Procedures

1. Hearing Aids (Hearing Aid)
2. Therapeutics
3. Lipreading (Lip Reading)
4. Transplantation
5. Cochlear Implants (Cochlear Implant)